Background: Behavioral programs may improve outcomes for individuals with type 2 diabetes mellitus, but there is a large diversity of behavioral interventions and uncertainty about how to optimize the effectiveness of these programs.
I
n 2012, 29.1 million Americans had diabetes with costs of $245 billion (1) , representing 11% of the total U.S. health care expenditure (2) . Although tight glycemic control may reduce the risk for microvascular complications in type 2 diabetes mellitus (T2DM) (3), behavioral and pharmacologic management of body weight, blood pressure, and cholesterol levels are often needed to reduce the risk for mortality and macrovascular complications. Moreover, other patient-centered outcomes, such as diabetes-related distress and depression, are important to address (4) .
Health care experts recommend that anyone with diabetes adopt and adhere to multiple self-care behaviors, including healthy eating, being active, monitoring, taking medication, problem-solving, healthy coping, and reducing risks (5) . Approaches to support behavior change include diabetes self-management education (DSME) with or without an added support (clinical, behavioral, psychosocial, or educational) phase, and lifestyle programs. Because knowledge acquisition insufficiently promotes behavioral changes (6) , recommendations for DSME have shifted from traditional didactic educational services to more patient-centered methodologies that incorporate interaction, problemsolving, and other behavioral approaches. Although evidence shows that diabetes-specific behavioral interventions can be effective, which combination of program components and delivery mechanisms is most effective is unclear (7) (8) (9) (10) (11) .
We conducted a network meta-analysis to identify factors related to program components and delivery mechanisms that moderate the effectiveness of multicomponent behavioral programs for T2DM.
Ovid, CINAHL Plus with Full Text via EBSCOhost, PsycINFO via Ovid, Scopus, and PubMed via the National Center for Biotechnology Information Databases. We reviewed the reference lists of relevant systematic reviews and of all included studies. We also searched ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform, relevant conference proceedings (2011 through 2014) , and the U.S. Federal Register.
Study Selection
We included studies conducted in highly developed countries published in English after 1993 (because medical management for diabetes intensified after this time). We included randomized, controlled trials done in community or outpatient health settings and involving adults that compared a behavioral program with usual care (medical management provided to all participants), an active control (intervention not meeting our definition of behavioral program), or another behavioral program (comparative effectiveness study). A behavioral program was a multicomponent, diabetes-specific program that included repeated interactions with trained individuals over at least 4 weeks, and that consisted of DSME using a behavioral approach or another program format including at least a structured dietary or physical activity intervention with another component (Appendix, available at www .annals.org).
We excluded abstracts and studies in which the intervention was a disease or care management program (for example, with active adjustment of diabetesrelated medications) (12) or a quality improvement program incorporating strategies targeting health systems or providers (13). Other exclusion criteria included studies 1) focusing on patients with newly diagnosed (≤1 year) disease; 2) with no outcome of interest to this review (for example, only C-reactive protein), or in which the only difference between the study groups was a factor outside of the review's scope (for example, low-vs. high-fat diet); and 3) in which 25% or more of the participants had type 1 diabetes mellitus (unless results were reported for those with T2DM).
Two reviewers independently screened all titles and abstracts, and the full text of any publication marked for inclusion was retrieved. Two reviewers independently assessed the full texts by using a priori inclusion criteria and a standard form. We resolved disagreements by consensus or consultation with a third reviewer.
Data Extraction and Quality Assessment
One reviewer extracted data by using a structured form created in the Systematic Review Data Repository (available at http://srdr.ahrq.gov/) (14); a second reviewer verified data. Two reviewers independently applied the Cochrane risk of bias tool (15). Discrepancies were resolved through discussion.
Data Synthesis and Analysis
With input from technical experts, we categorized behavioral programs by various component and delivery factors (Table) . We separated DSME and DSME plus support, in recognition that the support phase of the latter was often of lower intensity (less frequent contacts) and focused on different content, such as psychosocial support.
To serve as an overview of program effectiveness and help interpret our primary analysis of program moderation, we performed pairwise meta-analyses by using the Hartung-Knapp-Sidik-Jonkman randomeffects model (16, 17) for multiple behavioral, clinical, and health outcomes, as well as health care utilization and program acceptability (the full report is available at www.ahrq.gov/research/findings/evidence-based -reports/). We defined thresholds for clinical importance where there was guidance: For hemoglobin A 1c (HbA 1c ), we used a reduction of at least 0.4% (for example, 7.6% vs. 8.0%) (18); for quality-of-life measures and other patient-reported outcomes, we used a conservative value of one-half SD (19, 20) .
We then conducted a network meta-analysis that allowed simultaneous evaluation of a suite of comparisons and considered both direct and indirect evidence while preserving the within-study randomization. To assure the transitivity within the network, we categorized all behavioral programs and comparators into nodes. The nodes for behavioral programs were formed on the basis of different combinations of variables in our program categorization (Appendix Table 2 , available at www.annals.org); we identified all plausible nodes differing by only one variable (for example, a level within the intensity category) and then "filled" the nodes with the applicable interventions on the basis of our coding. The nodes for the comparator groups were categorized as usual care, active non-DSME control (education interventions not meeting our criteria), and active other control (for example, stand-alone dietary or physical activity interventions).
The analysis was conducted by using a Bayesian network model to compare all interventions simultaneously and to use all available information on treatment effects in a single analysis (21, 22) . These methods ensure that correlation in multigroup trials is preserved. Mean differences (MDs) were modeled using noninformative prior distributions. A normal prior distribution with mean 0 and large variance (10 000) was used for each of the trial means, whereas their between study variance had a uniform prior with range 0 to 2. These priors were checked for influence with sensitivity analyses. Markov chain Monte Carlo simulations using WinBugs software were performed to obtain simultaneous estimates of all interventions compared with placebo, as well as estimates of which interventions were the best. A burn-in sample of 20 000 iterations was followed by 300 000 iterations used to compute estimates. A sensitivity analysis that thinned the amount of used data to every 10th iteration was also conducted to check for proper chain convergence. The analysis was checked for consistency by contrasting direct and indirect estimates in each triangular and quadratic loop by using the methods described by Veroniki and colleagues (23). Results are presented as estimates of the treatment effects (MD) relative to usual care, with 95% credible intervals.
To examine different population subgroups, we conducted subgroup analyses of the pairwise metaanalysis results for HbA 1c at longest follow-up in comparison with usual care and active controls; subgroups were defined on the basis of study-level baseline HbA 1c (<7% vs. ≥7%), age (<65 vs. ≥65 years), and ethnicity (≥75 vs. <75% nonwhite), according to categories that were defined a priori. For baseline HbA 1c level and age, we performed subgroup analyses of the network meta-analysis; the analysis was rerun for studies having a mean baseline HbA 1c level of 7% or greater and for those with a mean participant age younger than 65 years. For subgroups based on race/ethnicity, the number of trials in either subgroup was insufficient to perform a network meta-analysis.
Role of the Funding Source
This project was funded under contract 290-2012-000131 from the AHRQ, U.S. Department of Health and Human Services. Staff at AHRQ participated in development of the scope of the work and reviewed drafts of the manuscript. Approval by AHRQ was required before the manuscript could be submitted for publication, but the authors are solely responsible for its content and the decision to submit for publication. AHRQ staff did not participate in the conduct of the review, data selection or collection, data analysis, interpretation of the data, or preparation of the manuscript.
RESULTS
Searches identified 47 152 citations; we included 132 randomized, controlled trials (24 -154; Zgibor J, Piatt G. Project Seed: support, education and evaluation in diabetes. 2014. Unpublished report) described in 161 publications ( Figure 1 ). The online report lists excluded studies and associated publications. Appendix Table 2 includes characteristics of studies. Tests for publication bias showed no important bias; the Egger test (155) for HbA 1c was not significant for comparisons with usual care (P = 0.25) or active controls (P = 0.21) at the end of the intervention.
Most randomized, controlled trials had 2 groups, but several trials evaluated more than 1 behavioral program, for 166 intervention groups in total. Trials were conducted in 16 countries-the majority (63%) were in the United States, and the remainder were conducted 2. Moderate/maximum: most of the program has content and/or delivery tailoring (e.g., topics are based on needs assessment and delivery timing, duration, or location is based on the participant's schedule, needs, or location preferences) Level and nature of community engagement* 1. Present: For example, peer delivering program or peer support groups for support stage, use of community resources (infrastructure) for delivery or maintenance stages 2. Absent: For example, nothing reported or, at most, providing written information about community resources DSME = diabetes self-management education. * Only used for regression analyses as reported in the full technical report and related article on type 1 diabetes mellitus in this issue. † Where contact hours could not be calculated, we used number of contacts as a proxy. ‡ The cut points used for creating the intensity categories were based on practical considerations. The 10-h "minimal intensity" limit was based on the current number of hours billable for patients eligible for public health care administered by the Centers for Medicare & Medicaid Services in the United States; this was described by our technical expert panel as an important practical limitation on implementing programs having higher intensity. § 2 and 3 were combined for analysis. 1 and 2 were combined for analysis. ¶ Used in summary tables.
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in Canada (n = 6); Korea and the United Kingdom (n = 5 each); Australia, Hong Kong, and the Netherlands (n = 4 each); and Germany and Japan (n = 3 each). Mean participant age was 45 to 72 years (median, 58 years). Baseline HbA 1c level was between 6.3% and 12.3% (median, 8%). Body mass index ranged from 23.8 to 39.1 kg/m 2 (median, 33.0 kg/m 2 ). Median duration of diabetes was 8.1 years (range, 1 to 18 years). Thirty-two trials (24%) were conducted with participants who self-identified as a minority ethnic (nonwhite) background.
All trials had medium or high overall risk of bias. For objective outcomes, 42% had medium and 58% had high risk, largely driven by incomplete outcome data. For trials (n = 92) reporting on subjective outcomes of interest (such as health-related quality of life or depression), 13% had medium risk of bias; the remainder (87%) had high risk of bias, largely owing to lack of blinding of participants, personnel, and outcome assessors.
Results from pairwise meta-analyses of all outcomes are presented in Appendix , and 12 months postintervention (MD, Ϫ0.14 [CI, Ϫ0.4 to 0.12]; 9 comparisons; 1494 participants); however, the reduction achieved was not considered clinically important at any of the 3 time points. Results were even more modest for behavioral programs compared with active control groups: The MD was Ϫ0.24 (CI, Ϫ0.41 to Ϫ0.07; 25 comparisons; 7518 participants) at the end of the intervention, Ϫ0.19 (CI, Ϫ0.37 to Ϫ0.01; 6 comparisons; 595 participants) at 6 months, and Ϫ1.10 (CI, Ϫ2.56 to 0.36; 6 comparisons; 486 participants) at 12 months. High heterogeneity (I 2 = 62% to 98%) in the meta-analyses supported our planned evaluation of which program components and delivery factors moderate effectiveness.
In Figure 2 , Appendix Table 6 (available at www .annals.org), and Appendix Figure 1 (available at www.annals.org) summarize the results of the network meta-analysis for HbA 1c at longest follow-up (102 trials; 19 565 participants). Figure 2 shows the combined estimates (vs. usual care) of all nodes, rank-ordered by relative effectiveness, from the most effective to the least effective. Each estimated effect is for a group of programs having a similar combination of program component; intensity; method of communication; delivery method; and for DSME programs only, because of having more comparisons, delivery personnel. Program duration and community engagement were not incorporated because of overlap with intensity and delivery personnel, respectively; most studies were scored as including community engagement solely through use of peers or lay providers in delivery. Program tailoring was not incorporated because of difficulty in distinguishing between minimal and moderate tailoring on the basis of reporting. Most results were from studies with follow-up of 6 months or less, with 8 studies contributing 12-month follow-up data. When interpreting results, we considered the relative ranking of nodes and looked for trends in findings on the basis of program variables that seemed to determine whether the effects would offer clinical benefit. Some nodes had very few studies, small sample sizes, or wide credible intervals; thus, we did not make firm conclusions for a single node (or for differences in 561 potential comparisons), but rather from looking across nodes with similar features. A consistency analysis was performed for the HbA 1c analysis; only 2 quadratic loops (of a total of 43 quadratic and triangular loops) showed statistically significant inconsistency. Records from reference lists of systematic reviews and included studies (n = 11)
Moderation of Effectiveness, by Program Components and Delivery Mechanisms
With usual care as the reference, behavioral programs showing effect sizes for HbA 1c meeting or exceeding our threshold for clinical importance represented all 3 major program component categories of DSME (4 nodes), DSME and support (5 nodes), and lifestyle (5 nodes). Among programs showing clinically important effects, 6 represented medium-intensity programs (11 to 26 contact hours), 6 represented highintensity programs (≥26 hours), and 2 represented lowintensity programs (≤10 hours). Mean contact hours for the programs represented by these effective nodes was 26.4 (range, 7 to 40.5 hours); mean total program duration was 8 months (range, 2 to 12 months). None of the nodes representing low-intensity (≤10 hours) DSME programs showed clinically important effects; all had a greater effect on HbA 1c than basic educational controls, but less effect than a stand-alone dietary or physical activity intervention. Three of four nodes representing DSME programs with effect estimates showing clinically important effects were delivered by health care professionals. Eleven of the 14 nodes representing clinically important effects were delivered in person rather than incorporating some form of technology; effective programs incorporating technology were all of moderate or high intensity (>10 hours).
Network meta-analysis was also conducted for BMI (Appendix Figure 2 and Appendix Table 7 , both available at www.annals.org). The mean study-level baseline BMI was similar for programs classified as DSME (32.4 kg/m 2 ), DSME and support (33.0 kg/m 2 ), and lifestyle (32.9 kg/m 2 ). Behavioral programs changed BMI by Ϫ1.77 kg/m 2 to 3.29 kg/m 2 . Lifestyle programs resulted in the greatest changes. Program intensity seemed to 
Program Components and Delivery Factors
Change in HbA 1c Relative to Usual Care, % be less important than method of delivery. The majority of programs with the highest MDs (that is, 8 of the highest 10 nodes) offered some individual delivery.
Subgroup Analyses
For behavioral programs compared with usual care, there was a small benefit (MD, Ϫ0.12 [CI, Ϫ0.22 to Ϫ0.01]; I 2 = 3%) in terms of HbA 1c reduction in studies where participants had a mean baseline HbA 1c level less than 7.0% (6 trials; 1239 participants) (87, 89, 118, 143, 147, 154 When 9 trials of participants who had good baseline glycemic control were excluded (65, 78, 87, 89, 94, 118, 143, 147, 154) , the results of the network metaanalysis were essentially the same as when data from all trials were incorporated. Effect sizes for nodes ranked 1 and 13 (see Figure 2 for categorization of these nodes) decreased to ranks of 31 and 23 (from Ϫ1.37 to 0.09 and from Ϫ0.45 to -0.15, respectively); the program formats represented by these nodes seem to have been more effective for participants with good glycemic control. In addition, the active (dietary or physical activity) control became less effective (MD, Ϫ0.14 vs. Ϫ0.39) for participants with HbA 1c levels of 7% or greater.
The participants in 9 studies reporting on HbA 1c had a mean age of 65 years or older (36, 44, 55, 89, 97, 113, 116, 118, 125, 132 (54, 64, 73, 91, 125) ; studies with a larger proportion of white participants also showed no difference (MD, Ϫ0.50 [CI, Ϫ1.24 to 0.23]; 10 comparisons; 6214 participants) (59, 60, 66, 76, 94, 95, 145, 150) . Of note, glycemic control at baseline seemed to be worse for minority participants than for majority or white subgroups (HbA 1c level, 8.80% vs. 7.60%, respectively).
DISCUSSION
We found that most lifestyle and DSME plus support programs (usually offering ≥11 contact hours) led to clinically important improvements in glycemic control (≥0.4% reduction in HbA 1c ), but that most DSME programs without an added support component provided little benefit-particularly when 10 or fewer hours of contact with delivery personnel was provided. Programs that were effective most often included inperson delivery rather than incorporation of technology. We also found that programs focused on lifestyleoften structured weight loss and physical activity interventions-or on DSME can have similar benefit in terms of glycemic control, and that lifestyle programs appear better for reducing BMI. Behavioral programs seem to benefit persons with suboptimal or poor glycemic control more than those with good control. Tailoring programs to ethnic minority groups, such as incorporating group interaction with peers, seems to be beneficial.
We built upon previous reviews examining factors that influence effectiveness of interventions for T2DM (8, 10, 11, 156) . We included the highest number of studies to date and focused on programs meeting current recommendations to change patient behaviors. We relied on strict inclusion criteria to study interactive programs incorporating behavioral strategies aiming to change multiple behaviors, without confounding by changes to medical management (e.g., medication changes). Our finding that single-topic, noneducational interventions (active controls of dietary or physical activity interventions) offer more benefit than do basic education interventions supports the need to carefully distinguish between and account for different comparators during the systematic review process. Our use of a network meta-analysis enabled differentiation of the various comparators, and incorporation of comparisons (e.g., intervention vs. intervention) often not amenable to other analytical strategies.
Our network meta-analysis results for HbA 1c suggest that both individual and group delivery are beneficial, consistent with other work in this area (157). Other factors (or a combination of factors) may influence outcomes; for instance, delivery format may be highly dependent upon the population served and program content. The studies offering group delivery that had high effect sizes tended to be those offered to minority groups, including Mexican Americans (39, 41, 102) , where support from peers was a key program feature.
We were unable to draw conclusions about the effectiveness of professional healthcare versus lay providers for delivery of behavioral programs. Evaluating the pairwise meta-analysis results for comparative effectiveness between 2 or more behavioral programs (Appendix Table 5 The more positive findings for patients with poorer glycemic control are consistent with those of previous systematic reviews (157). Intuitively, individuals with good glycemic control may not achieve as much benefit from behavioral programs-there is little room for improvement, and good self-management behaviors may already be practiced regularly. The findings for the ethnicity subgroups need to be interpreted in light of differences in baseline glycemic control, which seemed to be worse for the minority subgroup (HbA 1c level, 8.80%) compared with the majority/white subgroup (HbA 1c level, 7.60%); it is thus hard to distinguish whether ethnicity or glycemic control is more likely to have the greater influence in moderating program effectiveness.
Many trials with a large proportion of ethnic minorities also adapted programs to make them more culturally and linguistically acceptable-often by including peers in delivering or implementing social support groups-which may have enhanced their effectiveness. A previous systematic review (158), which found benefit of culturally tailored diabetes education, found that lower baseline HbA 1c levels better predicted positive responses to the programs. Our reliance on study-level data to create subgroups may have limited our ability to capture differences in effects from programs delivered to a wider population base, which may reflect routine practice in many community health settings.
Our study has limitations. First, our full search was conducted to January 2015; however, a search update to June 2015 in MEDLINE did not identify any large study with low risk of bias that may affect findings. In addition, systematic reviews are threatened by risks of selective reporting bias (e.g., studies only reporting positive outcomes); publication bias, in which unexpectedly strong results from large trials are selectively published; and selection bias. We were able to locate several trial registries and protocols to compare planned and published outcome reporting; most included studies had low bias in this respect. Our prespecified tests for publication bias provided no indication of important bias. Effect sizes in languagerestricted reviews have shown not to differ significantly from those without restrictions (159). Many trials had methodological limitations introducing some risk of bias.
Our findings should be interpreted on the basis of our approach to address program durability. Our analyses used outcome data at longest postintervention follow up, which for the majority of studies was between the end of the intervention and 6 months of follow-up. Only 8 of 112 trials had follow-up longer than 6 months; longer follow-up would allow for further evaluation of the effectiveness of these programs. Results from our pairwise meta-analyses for HbA 1c in T2DM at each follow-up time point indicated reduced effectiveness at follow-up durations longer than the end of intervention; this suggests that the mean effect sizes from our network meta-analysis at longest follow-up may underestimate the effects at the end of the intervention.
In conclusion, the effectiveness of behavioral programs on glycemic control was shown to be moderated to the greatest extent by program intensity and to a lesser extent by delivery personnel or format (e.g., individual vs. group). It seems that programs require a substantial amount of contact time or, for DSME-based programs, a support component to best train people in their self-care. Programs tailored to ethnic minorities seem to be beneficial; subgroup results by age suggest that tailoring of programs to older adults is needed. The addition of a technological aspect in the delivery did not seem to be as beneficial as in-person delivery, although more direct comparisons on this variable would be beneficial because of the potential for technology to enable participation of hard-to-reach populations. 
Behavioral Program
This was defined as an organized, multicomponent diabetes-specific program with repeated interactions* by 1 or more trained individuals, with a duration of 4 or more weeks, to improve disease control or patient health outcomes and consisting of at least 1 of: 1) DSME †; 2) a structured dietary intervention (related to any of weight loss, glycemic control, or reducing risk for complications), together with 1 or more additional components; or 3) a structured exercise or physical activity intervention, together with 1 or more additional components. Additional components for structured dietary interventions and structured exercise or physical activity interventions may include interventions related to diet or physical activity; behavioral change (including but not limited to goal-setting, problem-solving, motivational interviewing, coping skills training, and cognitive-behavioral therapy strategies); relaxation or stress reduction; blood glucose regulation; medication adherence; or self-monitoring for diabetic complications (foot, eye, and renal tests).
* Interactions must include contact with those delivering the program, rather than sole reliance on "interactive behavior change technology" (e.g., patientcentered websites, automated telephone calls, DVDs, or touch-screen kiosks).
† DSME programs included programs stated to meet standards for DSME in the respective country, or those 1) providing education or training to patients on several behaviors by using interactive approaches and 2) incorporating some form of behavioral change strategy whereby patients are taught to make informed decisions to self-manage their disease.
Comparators
These were usual care (usual medical management provided to all study groups, as defined by authors), active control (intervention beyond usual care but not meeting our operational definition of a behavioral program [e.g., stand-alone dietary intervention, basic education program of short duration or not including behavioral approaches]), and other behavioral programs. 59, 60, 65, 66, 74, 76, 78, 84, 85, 91, 95, 125, 145, 150 MD, Weight (kg) 15 (6212); 37, 43, 55, 56, 60, 65, 74, 76, 78, 84, 91, 95, 150 MD, (25, 31, 44, 48, 53, 61, 72, 85, 86, 92, 109, 118, 119, 131, 139, 154) 11-26
In person BMI = body mass index; DSME = diabetes self-management education; MD = mean difference; NA = not applicable.
